Article: Eisai Signs License Agreement with Biocompatibles International for Drug-Eluting Bead Products for Embolisation.

Article: Biocompatibles International plc - Statement re ...
PR Newswire UK Disclose;  April 27, 2009 ;     700+ words ... ... Biocompatibles" or the "Company") Drug-Eluting Bead Cancer Trials: Update on US Activities ... pleased to provide an update of Drug-Eluting Bead clinical trials in the United States ... completed a trial in which the Drug-Eluting Bead was used to treat 20 patients with primary ...

Article: Biocompatibles International plc - Statement re Drug ...
PR Newswire UK Disclose;  December 5, 2005 ;     700+ words ... ... International plc ("Biocompatibles" or "the Company") Drug Eluting Bead Programme Update * Recruitment of first patient in PRECISION ... pleased to announce four positive developments in its Drug Eluting Bead Programme. Recruitment of first patient in PRECISION V On ...

Article: Biocompatibles International plc - Research Update.
PR Newswire UK Disclose;  September 15, 2008 ;     700+ words ... ... Presented at CIRSE Drug-Eluting Bead shows significant benefit ... Risk Patients, Drug-Eluting Bead Arm has a higher Tumour ... Biocompatibles' Drug-Eluting Bead against a control arm of ... Embolisation of vessels supplying malignant hypervascularised tumour(s), - Delivery ...

Article: Biocompatibles International plc - PRECISION V Results.
PR Newswire UK Disclose;  August 15, 2008 ;     700+ words ... ... PRECISION V Results * Drug-Eluting Bead Arm has a higher Tumour ... 0.1135). * Drug-Eluting Bead Arm has a lower rate of ... Pharmaceuticals; Drug-Eluting Bead products for the treatment ... Embolisation of vessels supplying malignant hypervascularised tumour(s), - Delivery ...

Article: Biocompatibles International plc - Positive Survival Data.
PR Newswire UK Disclose;  May 8, 2007 ;     700+ words ... ... commented "The Drug Eluting Bead treatment was well ... data from our drug eluting bead programme continues ... proprietary drug eluting bead product developed ... the treatment of malignant hypervascularised tumours. Doxorubicin ...

Article: Biocompatibles International plc - Statement re START OF ...
PR Newswire UK Disclose;  February 9, 2006 ;     700+ words ... ... evaluation of the Drug Eluting Bead in lung cancer ... proprietary Drug Eluting Bead product containing ... proprietary drug eluting bead product developed ... the treatment of malignant hypervascularised tumours. PRECISION ...

Article: Biocompatibles International plc - Statement re Positive Data ...
PR Newswire UK Disclose;  June 5, 2006 ;     700+ words ... ... from the Company's Drug Eluting Bead programme. At the annual ... TACE procedures to Drug Eluting Bead products, to be around ... Biocompatibles' proprietary drug eluting bead product developed for loading ... 2003 for the treatment of malignant hypervascularised tumours. ...